Other OTC - Delayed Quote USD

Deltagen Inc. (DGEN)

0.0000 0.0000 (0.00%)
At close: January 29 at 2:48 PM EST

Key Executives

Amounts are as of December 31, 2006 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Dr. Robert J. Driscoll CEO, President, Secretary & Director 411k -- 1966
Mr. Daniel Ratto Chief Financial Officer 105.3k -- 1958

Deltagen Inc.

1900 South Norfolk Street
Suite 105
San Mateo, CA 94403
United States
650-345-7601 https://www.deltagen.com
Sector: 
Healthcare

Description

Deltagen Inc. provides drug discovery tools and services to the biopharmaceutical industry. The company offers a suite of programs designed to enhance the efficiency of drug discovery, including access to biological models, as well as small-molecule and secreted protein drug targets. It also provides target validation data in the areas of immunology and metabolic diseases. The company was incorporated in 1999 and is headquartered in San Mateo, California.

Corporate Governance

Deltagen Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Recent Events

  • May 31, 2007
    Dividend Date
  • May 17, 2007
    Ex-Dividend Date

Upcoming Events